Estimation Of The Effect Of Denosumab On Bone Loss From The Results Of The 12-Month Phase II Study In Patients With Rheumatoid Arthritis (RA) On Background Methotrexate (MTX)
Author(s):
Tanaka, Y.; Takeuchi, T.; Ishiguro, N.; Yamanaka, H.; Yoneda, T.; Genant, H.K.; Heijde, D. van der
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S585-S585